New Zealand markets open in 9 hours 45 minutes

Spyre Therapeutics, Inc. (SYRE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
36.49+2.82 (+8.38%)
At close: 04:00PM EDT
36.49 0.00 (0.00%)
After hours: 05:05PM EDT
Major holders
Insider roster

Insider transactions

Currency in USD
Insider purchases - Last 6 monthsSharesTrans
Purchases00
SalesN/A0
Net shares purchased (sold)00
Total insider shares held1.59MN/A
% net shares purchased (sold)N/AN/A
Net institutional purchases - Prior quarter to latest quarterShares
Net shares purchased (sold)N/A
% change in institutional shares heldN/A

Insider transactions reported - last two years

InsiderTransactionTypeValueDateShares

TURTLE CAMERON
Chief Executive Officer

Stock Award(Grant) at price 22.56 per share.Direct9,02415 Feb 2024400

BURROWS SCOTT L.
Chief Financial Officer

Stock Award(Grant) at price 0.00 per share.Direct022 Dec 2023134,953

ALBERS JEFFREY W
Director

Indirect24 Nov 202334,360

TURTLE CAMERON
Chief Executive Officer

Direct24 Nov 2023723,440

FAIRMOUNT FUNDS MANAGEMENT LLC
Beneficial Owner of more than 10% of a Class of Security

Indirect24 Nov 20233,435,480

SOUZA MARCIO SILVA DE
Director

Purchase at price 0.56 per share.Direct50,47225 Aug 202290,000

HANLEY MICHAEL CONICK JR.
Officer

Purchase at price 0.71 per share.Direct20,02208 Jun 202228,200

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 2.34 per share.Direct187,70516 Mar 202280,079

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 1.86 - 2.06 per share.Direct280,94315 Mar 2022144,666

ALSPAUGH JONATHAN D.
Chief Financial Officer

Purchase at price 2.08 per share.Direct156,00011 Mar 202275,000

SHANAFELT ARMEN B
Director

Purchase at price 3.65 - 3.67 per share.Direct549,69213 Dec 2021150,000

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 3.70 - 3.75 per share.Direct198,97210 Dec 202153,634

ALSPAUGH JONATHAN D.
Chief Financial Officer

Purchase at price 3.72 per share.Direct186,00009 Dec 202150,000

QUINN ANTHONY G
Chief Executive Officer

Stock Gift at price 0.00 per share.Direct020 Oct 2021266,295

ALSPAUGH JONATHAN D.
Chief Financial Officer

Purchase at price 6.37 - 6.72 per share.Direct262,66018 Aug 202140,372

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 7.77 per share.Direct1,282,05030 Apr 2020165,000

QUINN ANTHONY G
Chief Executive Officer

Conversion of Exercise of derivative security at price 5.46 - 6.31 per share.Direct114,68904 Oct 201918,265

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 6.11 - 6.23 per share.Direct196,45314 Jun 201931,905

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 6.55 - 6.89 per share.Direct180,03222 May 201926,592

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 6.65 - 7.10 per share.Direct126,39917 May 201918,713

QUINN ANTHONY G
Chief Executive Officer

Conversion of Exercise of derivative security at price 5.46 - 6.31 per share.Direct54,12606 Feb 20198,756

QUINN ANTHONY G
Chief Executive Officer

Conversion of Exercise of derivative security at price 4.11 - 6.31 per share.Direct751,81607 Dec 2018171,890

SCHUCHART AARON
Officer

Sale at price 9.50 - 9.55 per share.Direct57,00527 Sept 20186,000

SCHUCHART AARON
Officer

Conversion of Exercise of derivative security at price 3.50 per share.Direct29,75017 Aug 20188,500

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 6.02 - 9.13 per share.Direct21,11515 Aug 20182,994

GEORGIOU GEORGE
Director

Conversion of Exercise of derivative security at price 4.73 - 7.28 per share.Direct220,78413 Aug 201837,333

QUINN ANTHONY G
Chief Executive Officer

Conversion of Exercise of derivative security at price 6.31 - 7.04 per share.Direct262,76412 Jul 201838,866

QUINN ANTHONY G
Chief Executive Officer

Conversion of Exercise of derivative security at price 5.46 per share.Direct18,05611 Jul 20183,307

NOVARTIS BIOVENTURES, LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 10.06 per share.Indirect196,67311 May 201819,550

NOVARTIS BIOVENTURES, LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 10.11 - 10.13 per share.Indirect748,14010 May 201873,955

NOVARTIS BIOVENTURES, LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 10.03 - 10.11 per share.Direct423,55708 May 201842,105

QUINN ANTHONY G
Chief Executive Officer

Conversion of Exercise of derivative security at price 5.46 per share.Direct83,05215 Feb 201815,211

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 4.92 - 5.07 per share.Direct41,07808 Dec 20178,288

QUINN ANTHONY G
Director

Purchase at price 4.53 - 4.98 per share.Direct83,17705 Dec 201717,121

YORK CHARLES N. II CPA
Chief Financial Officer

Purchase at price 2.52 - 4.97 per share.Direct116,22305 Dec 201725,959

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 5.04 - 5.36 per share.Indirect563,88221 Feb 2017109,300

ELI LILLY & CO
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 10.00 per share.Indirect5,000,00012 Apr 2016500,000

ELI LILLY & CO
Beneficial Owner of more than 10% of a Class of Security

Indirect12 Apr 20162,010,924

TYLER JOSEPH E
Officer

Direct12 Apr 201631,260

NOVARTIS BIOVENTURES, LTD.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 10.00 per share.Indirect3,000,00012 Apr 2016300,000

NOVARTIS BIOVENTURES, LTD.
Beneficial Owner of more than 10% of a Class of Security

Indirect12 Apr 20162,010,924

LOWE DAVID GEORGE
Chief Executive Officer

Indirect12 Apr 20165,658

COX RUSSELL J
Director

Purchase at price 10.00 per share.Direct70,00012 Apr 20167,000

QUINN ANTHONY G
Director

Purchase at price 10.00 per share.Direct100,00012 Apr 201610,000

YORK CHARLES N. II CPA
Chief Financial Officer

Indirect12 Apr 201612,884

ROWLINSON SCOTT W
Officer

Indirect12 Apr 201611,204